SpaceX shares closed Friday at $112, down 12% from the $127 IPO price set April 14th, marking the largest first-week decline for a technology offering above $100B valuation since Rivian's 2021 debut. The $3.2B retail tranche—representing 8% of the $40B total raise—remains contested across four lead underwriters, with final allocation notices delayed past the standard T+2 settlement window.
The offering priced at the low end of its $125-$135 range after anchor institutional demand softened in the final 48 hours, according to syndicate desks. Trading volume in the first three sessions averaged 47M shares daily, 2.3x the projected steady-state figure, with block trades above 500K shares accounting for 68% of total volume—a profile consistent with institutional re-positioning rather than retail accumulation. The company's $210B post-IPO valuation implies a 14.2x forward revenue multiple, compressed from the 18x secondary market prints seen in late 2024 private transactions.
The retail allocation dispute centers on Morgan Stanley's decision to withhold $1.1B of its $1.8B retail book pending clarification on FINRA Rule 5130 compliance, specifically whether SpaceX employees participating in the directed share program qualify as restricted persons under the anti-flipping provisions. Goldman Sachs and JPMorgan allocated their retail tranches in full by Wednesday, creating a two-tier retail market where timing of access varied by 72 hours depending on custodian. This sequencing mismatch amplified day-two selling pressure as early retail allocations met institutional distribution flow.
The volatility signals a structural mismatch between the 18-month institutional lock-up—which binds 73% of pre-IPO holders through October 2026—and the unconstrained retail float, which now represents 19% of the free float despite being 8% of the raise. Single-family offices and crossover funds that participated in the last private round at $112/share equivalent are underwater on a mark-to-market basis for the first time since Q2 2023, though none are inside their lock-up release windows. The embedded tension is between holders who priced long-term infrastructure exposure and new buyers who expected the Starship program's Q3 commercial launch cadence to support immediate multiple expansion.
Allocators should monitor three near-term catalysts: the May 12th lock-up agreement publication, which will clarify whether early employees face six-month or twelve-month restrictions; the Q2 earnings call scheduled for late July, SpaceX's first as a public company, where Starlink subscriber growth and Starship cost-per-launch metrics will set the margin trajectory narrative; and the SEC's response to the retail allocation delay, expected within 30 days, which could establish new precedent for employee-directed share treatment in mega-cap technology IPOs. The Morgan Stanley retail tranche remains in limbo, with no updated guidance provided to participating accounts as of Friday's close.
The stock's $15 range in five trading days represents 13.4% of the offering price—wider than the 8.2% median first-week range for the 2024 IPO class above $5B in proceeds, but tighter than Rivian's 28% swing. What matters is not the volatility itself but what it reveals: institutions priced a satellite-internet utility with rocket upside, while retail priced a rocket company with satellite income.